24 related articles for article (PubMed ID: 26359225)
1. Additional evidence for the 'wimp SNP' concept of carcinogenesis.
Bolt HM
EXCLI J; 2017; 16():1230-1232. PubMed ID: 29285018
[No Abstract] [Full Text] [Related]
2. The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence.
Kuo CC; Moon KA; Wang SL; Silbergeld E; Navas-Acien A
Environ Health Perspect; 2017 Aug; 125(8):087001. PubMed ID: 28796632
[TBL] [Abstract][Full Text] [Related]
3. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
4. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
7. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma.
Huang CY; Pu YS; Shiue HS; Chen WJ; Lin YC; Hsueh YM
Arch Toxicol; 2016 Aug; 90(8):1917-27. PubMed ID: 26359225
[TBL] [Abstract][Full Text] [Related]
9. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk.
Park J; Chen L; Tockman MS; Elahi A; Lazarus P
Pharmacogenetics; 2004 Feb; 14(2):103-9. PubMed ID: 15077011
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature.
Weiss JM; Goode EL; Ladiges WC; Ulrich CM
Mol Carcinog; 2005 Mar; 42(3):127-41. PubMed ID: 15584022
[TBL] [Abstract][Full Text] [Related]
11. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
Li H; Hao X; Zhang W; Wei Q; Chen K
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
[TBL] [Abstract][Full Text] [Related]
12. Urinary 8-oxo-2'-deoxyguanosine: redox regulation of DNA repair in vivo?
Lunec J; Holloway KA; Cooke MS; Faux S; Griffiths HR; Evans MD
Free Radic Biol Med; 2002 Oct; 33(7):875-85. PubMed ID: 12361799
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
